Review



recombinant rat lep  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems recombinant rat lep
    Recombinant Rat Lep, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 39 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant rat lep/product/R&D Systems
    Average 93 stars, based on 39 article reviews
    recombinant rat lep - by Bioz Stars, 2026-06
    93/100 stars

    Images



    Similar Products

    93
    R&D Systems recombinant rat lep
    Recombinant Rat Lep, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant rat lep/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    recombinant rat lep - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    94
    R&D Systems recombinant rat leptin lep
    Fig. 3: <t>Leptin</t> induces osteogenic differentiation of TDSCs in vitro through activating the
    Recombinant Rat Leptin Lep, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant rat leptin lep/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    recombinant rat leptin lep - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    90
    GenScript corporation rat recombinant lep
    ( A ) Daily food intake (Means ± SD) for WT (n = 5) and <t>Lep</t> ∆ I14/ ∆ I14 (n = 6) measured over 7–8 weeks. *P < 0.05 vs. controls. **P < 0.01 vs. controls. ***P < 0.001 vs. controls. ( B ) Body weight was measured over 9 weeks for WT (n = 5) and Lep ∆ I14/ ∆ I14 males (n = 6) and WT (n = 6) and Lep ∆ I14/ ∆ I14 females (n = 6). *P < 0.01 vs. controls. **P < 0.01 vs. controls. ***P < 0.001 vs. controls. ( C ) Serum INSULIN level in 8-wk-old male WT (n = 4) and Lep ∆ I14/ ∆ I14 rats (n = 5), and female WT (n = 4) and Lep ∆ I14/ ∆ I14 rats (n = 6). ***P < 0.001 vs. controls. ( D ) Male WT (n = 5) and Lep ∆ I14/ ∆ I14 rats (n = 6) at age of wk-16 were ip injected with D-glucose, and serum glucose levels were determined at 0, 30, 60, 90, and 120 min after administration. *P < 0.05 vs. controls. ( E ) Hyperphagia and obesity were rescued by subcutaneous infusion of <t>recombinant</t> LEP. Two individual female Lep ∆ I14/ ∆ I14 rats were treated with rat recombinant Lep via subcutaneous implantation of an Alzet osmotic minipump (200 μg/kg/day) for 7 days before switching LEP to saline, while the WT female controls (n = 3) were implanted with a saline-filled minipump. For Lep ∆ I14/ ∆ I14 rats, solid arrow indicates the start of LEP treatment; solid arrowhead indicates the switch of LEP to saline. For WT controls, open arrow indicates the start of minipump implantation; open arrowhead indicates withdrawal of minipump. Numbers near each body-weight point are the daily food intake (g) measured on the same day.
    Rat Recombinant Lep, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat recombinant lep/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    rat recombinant lep - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    PeproTech recombinant rat lep
    ( A ) Daily food intake (Means ± SD) for WT (n = 5) and <t>Lep</t> ∆ I14/ ∆ I14 (n = 6) measured over 7–8 weeks. *P < 0.05 vs. controls. **P < 0.01 vs. controls. ***P < 0.001 vs. controls. ( B ) Body weight was measured over 9 weeks for WT (n = 5) and Lep ∆ I14/ ∆ I14 males (n = 6) and WT (n = 6) and Lep ∆ I14/ ∆ I14 females (n = 6). *P < 0.01 vs. controls. **P < 0.01 vs. controls. ***P < 0.001 vs. controls. ( C ) Serum INSULIN level in 8-wk-old male WT (n = 4) and Lep ∆ I14/ ∆ I14 rats (n = 5), and female WT (n = 4) and Lep ∆ I14/ ∆ I14 rats (n = 6). ***P < 0.001 vs. controls. ( D ) Male WT (n = 5) and Lep ∆ I14/ ∆ I14 rats (n = 6) at age of wk-16 were ip injected with D-glucose, and serum glucose levels were determined at 0, 30, 60, 90, and 120 min after administration. *P < 0.05 vs. controls. ( E ) Hyperphagia and obesity were rescued by subcutaneous infusion of <t>recombinant</t> LEP. Two individual female Lep ∆ I14/ ∆ I14 rats were treated with rat recombinant Lep via subcutaneous implantation of an Alzet osmotic minipump (200 μg/kg/day) for 7 days before switching LEP to saline, while the WT female controls (n = 3) were implanted with a saline-filled minipump. For Lep ∆ I14/ ∆ I14 rats, solid arrow indicates the start of LEP treatment; solid arrowhead indicates the switch of LEP to saline. For WT controls, open arrow indicates the start of minipump implantation; open arrowhead indicates withdrawal of minipump. Numbers near each body-weight point are the daily food intake (g) measured on the same day.
    Recombinant Rat Lep, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant rat lep/product/PeproTech
    Average 90 stars, based on 1 article reviews
    recombinant rat lep - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    PeproTech recombinant rat leptin lep
    ( A ) Daily food intake (Means ± SD) for WT (n = 5) and <t>Lep</t> ∆ I14/ ∆ I14 (n = 6) measured over 7–8 weeks. *P < 0.05 vs. controls. **P < 0.01 vs. controls. ***P < 0.001 vs. controls. ( B ) Body weight was measured over 9 weeks for WT (n = 5) and Lep ∆ I14/ ∆ I14 males (n = 6) and WT (n = 6) and Lep ∆ I14/ ∆ I14 females (n = 6). *P < 0.01 vs. controls. **P < 0.01 vs. controls. ***P < 0.001 vs. controls. ( C ) Serum INSULIN level in 8-wk-old male WT (n = 4) and Lep ∆ I14/ ∆ I14 rats (n = 5), and female WT (n = 4) and Lep ∆ I14/ ∆ I14 rats (n = 6). ***P < 0.001 vs. controls. ( D ) Male WT (n = 5) and Lep ∆ I14/ ∆ I14 rats (n = 6) at age of wk-16 were ip injected with D-glucose, and serum glucose levels were determined at 0, 30, 60, 90, and 120 min after administration. *P < 0.05 vs. controls. ( E ) Hyperphagia and obesity were rescued by subcutaneous infusion of <t>recombinant</t> LEP. Two individual female Lep ∆ I14/ ∆ I14 rats were treated with rat recombinant Lep via subcutaneous implantation of an Alzet osmotic minipump (200 μg/kg/day) for 7 days before switching LEP to saline, while the WT female controls (n = 3) were implanted with a saline-filled minipump. For Lep ∆ I14/ ∆ I14 rats, solid arrow indicates the start of LEP treatment; solid arrowhead indicates the switch of LEP to saline. For WT controls, open arrow indicates the start of minipump implantation; open arrowhead indicates withdrawal of minipump. Numbers near each body-weight point are the daily food intake (g) measured on the same day.
    Recombinant Rat Leptin Lep, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant rat leptin lep/product/PeproTech
    Average 90 stars, based on 1 article reviews
    recombinant rat leptin lep - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    Image Search Results


    Fig. 3: Leptin induces osteogenic differentiation of TDSCs in vitro through activating the

    Journal: Journal of cellular physiology

    Article Title: Leptin accelerates the pathogenesis of heterotopic ossification in rat tendon tissues via mTORC1 signaling.

    doi: 10.1002/jcp.25955

    Figure Lengend Snippet: Fig. 3: Leptin induces osteogenic differentiation of TDSCs in vitro through activating the

    Article Snippet: Rats in HO+LEP+RA group (n=20) were injected with 0.2 ml of 80 μg recombinant rat leptin (LEP) (rrleptin, R&D systems, Minneapolis, MN) once a week in the region surrounding Achilles tendon.

    Techniques: In Vitro

    Fig. 5: Leptin treatment-induced increased osteogenic differentiation in tendon tissue with

    Journal: Journal of cellular physiology

    Article Title: Leptin accelerates the pathogenesis of heterotopic ossification in rat tendon tissues via mTORC1 signaling.

    doi: 10.1002/jcp.25955

    Figure Lengend Snippet: Fig. 5: Leptin treatment-induced increased osteogenic differentiation in tendon tissue with

    Article Snippet: Rats in HO+LEP+RA group (n=20) were injected with 0.2 ml of 80 μg recombinant rat leptin (LEP) (rrleptin, R&D systems, Minneapolis, MN) once a week in the region surrounding Achilles tendon.

    Techniques:

    Fig. 7: Leptin promotes the osteogenic differentiation of tendon-derived stem cells (TDSCs)

    Journal: Journal of cellular physiology

    Article Title: Leptin accelerates the pathogenesis of heterotopic ossification in rat tendon tissues via mTORC1 signaling.

    doi: 10.1002/jcp.25955

    Figure Lengend Snippet: Fig. 7: Leptin promotes the osteogenic differentiation of tendon-derived stem cells (TDSCs)

    Article Snippet: Rats in HO+LEP+RA group (n=20) were injected with 0.2 ml of 80 μg recombinant rat leptin (LEP) (rrleptin, R&D systems, Minneapolis, MN) once a week in the region surrounding Achilles tendon.

    Techniques: Derivative Assay

    ( A ) Daily food intake (Means ± SD) for WT (n = 5) and Lep ∆ I14/ ∆ I14 (n = 6) measured over 7–8 weeks. *P < 0.05 vs. controls. **P < 0.01 vs. controls. ***P < 0.001 vs. controls. ( B ) Body weight was measured over 9 weeks for WT (n = 5) and Lep ∆ I14/ ∆ I14 males (n = 6) and WT (n = 6) and Lep ∆ I14/ ∆ I14 females (n = 6). *P < 0.01 vs. controls. **P < 0.01 vs. controls. ***P < 0.001 vs. controls. ( C ) Serum INSULIN level in 8-wk-old male WT (n = 4) and Lep ∆ I14/ ∆ I14 rats (n = 5), and female WT (n = 4) and Lep ∆ I14/ ∆ I14 rats (n = 6). ***P < 0.001 vs. controls. ( D ) Male WT (n = 5) and Lep ∆ I14/ ∆ I14 rats (n = 6) at age of wk-16 were ip injected with D-glucose, and serum glucose levels were determined at 0, 30, 60, 90, and 120 min after administration. *P < 0.05 vs. controls. ( E ) Hyperphagia and obesity were rescued by subcutaneous infusion of recombinant LEP. Two individual female Lep ∆ I14/ ∆ I14 rats were treated with rat recombinant Lep via subcutaneous implantation of an Alzet osmotic minipump (200 μg/kg/day) for 7 days before switching LEP to saline, while the WT female controls (n = 3) were implanted with a saline-filled minipump. For Lep ∆ I14/ ∆ I14 rats, solid arrow indicates the start of LEP treatment; solid arrowhead indicates the switch of LEP to saline. For WT controls, open arrow indicates the start of minipump implantation; open arrowhead indicates withdrawal of minipump. Numbers near each body-weight point are the daily food intake (g) measured on the same day.

    Journal: Scientific Reports

    Article Title: The 14th Ile residue is essential for Leptin function in regulating energy homeostasis in rat

    doi: 10.1038/srep28508

    Figure Lengend Snippet: ( A ) Daily food intake (Means ± SD) for WT (n = 5) and Lep ∆ I14/ ∆ I14 (n = 6) measured over 7–8 weeks. *P < 0.05 vs. controls. **P < 0.01 vs. controls. ***P < 0.001 vs. controls. ( B ) Body weight was measured over 9 weeks for WT (n = 5) and Lep ∆ I14/ ∆ I14 males (n = 6) and WT (n = 6) and Lep ∆ I14/ ∆ I14 females (n = 6). *P < 0.01 vs. controls. **P < 0.01 vs. controls. ***P < 0.001 vs. controls. ( C ) Serum INSULIN level in 8-wk-old male WT (n = 4) and Lep ∆ I14/ ∆ I14 rats (n = 5), and female WT (n = 4) and Lep ∆ I14/ ∆ I14 rats (n = 6). ***P < 0.001 vs. controls. ( D ) Male WT (n = 5) and Lep ∆ I14/ ∆ I14 rats (n = 6) at age of wk-16 were ip injected with D-glucose, and serum glucose levels were determined at 0, 30, 60, 90, and 120 min after administration. *P < 0.05 vs. controls. ( E ) Hyperphagia and obesity were rescued by subcutaneous infusion of recombinant LEP. Two individual female Lep ∆ I14/ ∆ I14 rats were treated with rat recombinant Lep via subcutaneous implantation of an Alzet osmotic minipump (200 μg/kg/day) for 7 days before switching LEP to saline, while the WT female controls (n = 3) were implanted with a saline-filled minipump. For Lep ∆ I14/ ∆ I14 rats, solid arrow indicates the start of LEP treatment; solid arrowhead indicates the switch of LEP to saline. For WT controls, open arrow indicates the start of minipump implantation; open arrowhead indicates withdrawal of minipump. Numbers near each body-weight point are the daily food intake (g) measured on the same day.

    Article Snippet: Each Lep ∆ I14/ ∆ I14 rat was subcutaneously implanted an Alzet osmotic minipump (model 2001, Durect) filled with rat recombinant LEP (Genscript) at a dosage of 200 μg/kg/day (in sterile saline), while each WT rat was subcutaneously implanted an Alzet osmotic minipump (model 2001, Durect) filled with sterile saline as control.

    Techniques: Injection, Recombinant, Saline

    ( A ) Sanger-sequencing of the RT-PCR products showed that the Lep mRNA of Lep ∆ I14/ ∆ I14 rat had a deletion of 3 nucleotides ATC encoding an Ile residue. ( B ) Western blot showed that the mature LEP ∆I14 protein is stably expressed in the WAT of Lep ∆ I14/ ∆ I14 rats. Shown is one of three independent experiments. ( C ) ELISA showed that serum LEP ∆I14 in male Lep ∆ I14/ ∆ I14 rats (n = 5) is significantly increased compared to that of serum LEP WT in the male WT controls (n = 5). ( D ) Computer assimilation of LEP-LEPR interaction using available information from their human homologs: LEP (PDB number: 1AX8) and LEPR (PDB number: 3V6O). ( E ) STAT3 reporter assay. 293FT cells were treated with WT and mutant recombinant rat LEP proteins at different concentrations after transient transfection of pcDNA-Lepr, pRL-TK and pGL6-Stat3. Relative luciferase activity was determined by firefly luciferase light units normalized by that of renilla luciferase.

    Journal: Scientific Reports

    Article Title: The 14th Ile residue is essential for Leptin function in regulating energy homeostasis in rat

    doi: 10.1038/srep28508

    Figure Lengend Snippet: ( A ) Sanger-sequencing of the RT-PCR products showed that the Lep mRNA of Lep ∆ I14/ ∆ I14 rat had a deletion of 3 nucleotides ATC encoding an Ile residue. ( B ) Western blot showed that the mature LEP ∆I14 protein is stably expressed in the WAT of Lep ∆ I14/ ∆ I14 rats. Shown is one of three independent experiments. ( C ) ELISA showed that serum LEP ∆I14 in male Lep ∆ I14/ ∆ I14 rats (n = 5) is significantly increased compared to that of serum LEP WT in the male WT controls (n = 5). ( D ) Computer assimilation of LEP-LEPR interaction using available information from their human homologs: LEP (PDB number: 1AX8) and LEPR (PDB number: 3V6O). ( E ) STAT3 reporter assay. 293FT cells were treated with WT and mutant recombinant rat LEP proteins at different concentrations after transient transfection of pcDNA-Lepr, pRL-TK and pGL6-Stat3. Relative luciferase activity was determined by firefly luciferase light units normalized by that of renilla luciferase.

    Article Snippet: Each Lep ∆ I14/ ∆ I14 rat was subcutaneously implanted an Alzet osmotic minipump (model 2001, Durect) filled with rat recombinant LEP (Genscript) at a dosage of 200 μg/kg/day (in sterile saline), while each WT rat was subcutaneously implanted an Alzet osmotic minipump (model 2001, Durect) filled with sterile saline as control.

    Techniques: Sequencing, Reverse Transcription Polymerase Chain Reaction, Residue, Western Blot, Stable Transfection, Enzyme-linked Immunosorbent Assay, Reporter Assay, Mutagenesis, Recombinant, Transfection, Luciferase, Activity Assay